// IP Marketing video - START// IP Marketing video - END

U.S. approves HIV-prevention drug

U.S. approves HIV-prevention drug

PanARMENIAN.Net - The U.S. has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes Aids, Belfast Telegraph said.

The Food and Drug Administration approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.

Gilead Sciences has marketed Truvada since 2004 as a treatment for people who are infected with the virus, but company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure.

A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42%, when accompanied by condoms and counselling.

 Top stories
The ARFD said in the statement it has examined the political and social situation in Armenia and its strategic development priorities.
Passenger traffic grew by 26.1% in Yerevan’s Zvartnots airport and by 402.1% in Shirak airport in Yerevan in the reporting period.
Air temperature is expected to soar to 40 degrees Celsius (104 degrees Fahrenheit) between July 2 and July 6 in Yerevan, Armenia.
Many of those who have come to Armenia have found shelter with their relatives or friends, who basically belong to a lower class of society.
Partner news